Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Miragen Therapeutics Inc
(NQ:
MGEN
)
23.03
USD
-1.90 (-7.62%)
Official Closing Price
Updated: 7:58 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Miragen Therapeutics Inc
< Previous
1
2
3
Next >
miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease
December 17, 2020
From
GlobeNewswire News Releases
miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
November 10, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Miragen Therapeutics, Trevena, Norwegian Cruise Line, American Resources, or Delta Air Lines?
October 30, 2020
InvestorsObserver issues critical PriceWatch Alerts for MGEN, TRVN, NCLH, AREC, and DAL.
From
PR Newswire
Thinking about buying stock in Miragen Therapeutics, Nio, Scholar Rock, General Electric, or Boeing?
October 28, 2020
InvestorsObserver issues critical PriceWatch Alerts for MGEN, NIO, SRRK, GE, and BA.
From
PR Newswire
miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.
October 28, 2020
From
GlobeNewswire News Releases
miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)
October 05, 2020
miRagen decides to discontinue further internal development of cobomarsen
From
GlobeNewswire News Releases
miRagen Announces Leadership Transition and Review of Strategic Alternatives
September 14, 2020
From
GlobeNewswire News Releases
miRagen Announces Results of Meeting With FDA Regarding the Design of Pivotal Trial for Cobomarsen in ATLL
August 20, 2020
From
GlobeNewswire News Releases
miRagen Reports Second Quarter 2020 Financial Results and Provides Business Updates
August 05, 2020
From
GlobeNewswire News Releases
miRagen to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
August 04, 2020
From
GlobeNewswire News Releases
Stochastic K% D% Indicates Bullish US Stocks: $CIDM $STM $MGEN
August 04, 2020
Tags
The Market Signal
From
The Market Signal
miRagen, Investigators from Goethe University and University Hospital Frankfurt and Servier Publish MRG-110 Phase 1 Pharmacodynamic Biomarker Data in Nucleic Acid Therapeutics
July 28, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Miragen Therapeutics, ChannelAdvisor, Northern Dynasty Minerals, Tiziana Life Sciences, or Tonix Pharmaceuticals?
July 24, 2020
InvestorsObserver issues critical PriceWatch Alerts for MGEN, ECOM, NAK, TLSA, and TNXP.
From
PR Newswire
Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma
July 23, 2020
From
GlobeNewswire News Releases
miRagen to Report Second Quarter 2020 Financial Results on August 5, 2020
July 22, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in New Age Beverages, Lexicon Pharmaceuticals, Miragen Therapeutics, Opko Health, or Niu Technologies?
July 21, 2020
InvestorsObserver issues critical PriceWatch Alerts for NBEV, LXRX, MGEN, OPK, and NIU.
From
PR Newswire
miRagen Regains Compliance With Nasdaq Listing Requirements
July 02, 2020
From
GlobeNewswire News Releases
miRagen Announces Encouraging Preclinical Safety and Efficacy Data for its Next-generation miR-29 Replacement Product Candidate Intended for the Treatment of Idiopathic Pulmonary Fibrosis
June 22, 2020
Key Opinion Leader call on IPF scheduled for 11 a.m. ET on Tuesday, June 23rd
From
GlobeNewswire News Releases
Thinking about buying stock in Virgin Galactic, Miragen Therapeutics, Nantkwest Inc, Agenus Inc, or Norwegian Cruise Line?
June 22, 2020
InvestorsObserver issues critical PriceWatch Alerts for SPCE, MGEN, NK, AGEN, and NCLH.
From
PR Newswire
miRagen Strengthens Leadership Team with Appointment of Lee Rauch as Chief Operating Officer
June 18, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Energous Corp, Miragen Therapeutics, Hertz, Kopin Corp, or MGM Resorts?
June 17, 2020
InvestorsObserver issues critical PriceWatch Alerts for WATT, MGEN, HTZ, KOPN, and MGM.
From
PR Newswire
miRagen to Host a Key Opinion Leader Call on Idiopathic Pulmonary Fibrosis on Tuesday, June 23rd
June 16, 2020
miRagen to announce encouraging new preclinical safety and efficacy data for MRG-229 in IPF on June 22nd; and provide an update on the development program during the KOL call
From
GlobeNewswire News Releases
miRagen to Present at the Jefferies 2020 Virtual Global Healthcare Conference
May 26, 2020
From
GlobeNewswire News Releases
miRagen Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 07, 2020
From
GlobeNewswire News Releases
miRagen Therapeutics to Report First Quarter 2020 Financial Results On May 7, 2020
April 23, 2020
From
GlobeNewswire News Releases
miRagen Reports Fourth Quarter and Full Year 2019 Financial Results
March 11, 2020
From
GlobeNewswire News Releases
miRagen Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on March 11, 2020
February 20, 2020
From
GlobeNewswire News Releases
miRagen Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
February 07, 2020
From
GlobeNewswire News Releases
miRagen Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
February 06, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Beyond Meat, Miragen Therapeutics, Microsoft, Nio, or Sunrun?
January 30, 2020
InvestorsObserver issues critical PriceWatch Alerts for BYND, MGEN, MSFT, NIO, and RUN.
From
PR Newswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.